The Biomedical Research Institute is an autonomous research centre within the College of Medicine, Dentistry and Nursing. It creates an environment that brings together molecular and cell biologists with clinical scientists to lead research programmes that have a direct application to the study of common complex human diseases. It currently comprises 21 research groups and approximately 150 staff, providing a focus of research excellence and infrastructure within the College. The Institute is a thriving place to work and this web site gives a flavour of who we are and what we do.
Professor Andrew Morris, Director of Biomedical Research Institute, has addressed Kuwaiti researchers on diabetes and its treatments. The full article can be seen in the Arab Times.
BRI scientists in collaboration with their colleagues in Edinburgh and Australia have discovered the role of the GSK3 enzyme as a chemical messenger suppressor in the brain that could lead to the development of new drugs to treat conditions such as Alzheimer's disease. Their findings are published in Nature Neuroscience.
See the University press release.
Principal Investigators at the Biomedical Research Institute will collaborate with colleagues in industry and academia across Europe in an exciting FP7 project to identify early biological indicators (‘biomarkers’) to help in drug safety and early prediction of cancer.
See the University press release.
del.icio.us
digg
reddit
facebook
stumbleupon